» Articles » PMID: 38591322

Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction

Overview
Date 2024 Apr 9
PMID 38591322
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Heart failure guidelines have recently introduced a narrow category with mildly reduced left ventricular ejection fraction (LVEF) (heart failure with mildly reduced ejection fraction; LVEF 41%-49%) between the previous categories of reduced (heart failure with reduced ejection fraction; LVEF ≤40%) and preserved (heart failure with preserved ejection fraction; LVEF ≥50%) ejection fraction. Grouping of continuous measurements into narrow categories can be questioned if their variability is high.

Methods And Results: We constructed a cohort of all 9716 new cases of chronic heart failure with an available LVEF in Stockholm, Sweden, from January 1, 2015, until December 31, 2020. All values of LVEF were collected over time, and patients were followed up until death, moving out of Stockholm, or end of study. Mixed models were used to quantify within-person variance in LVEF, and multistate Markov models, with death as an absorbing state, to quantify the stability of LVEF categories. LVEF values followed a normal distribution. The SD of the within-person variance in LVEF over time was 7.4%. The mean time spent in any LVEF category before transition to another category was on average <1 year for heart failure with mildly reduced ejection fraction. Probabilities of transitioning between categories during the first year were substantial; patients with heart failure with mildly reduced ejection fraction had a probability of <25% of remaining in that category 1 year later.

Conclusions: LVEF follows a normal distribution and has considerable variability over time, which may impose a risk for underuse of efficient treatment. The heart failure with mildly reduced ejection fraction category is especially inconstant. Assumptions of a patient's current LVEF should take this variability and the normal distribution of LVEF into account.

Citing Articles

Left Ventricular Ejection Fraction in Heart Failure: Crazy, Stupid Love-and Maybe, Redemption.

Packer M J Am Heart Assoc. 2024; 13(8):e034642.

PMID: 38591329 PMC: 11262510. DOI: 10.1161/JAHA.124.034642.

References
1.
Albert J, Lezius S, Stork S, Morbach C, Guder G, Frantz S . Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes. J Am Heart Assoc. 2021; 10(3):e017822. PMC: 7955416. DOI: 10.1161/JAHA.120.017822. View

2.
Kondo T, McMurray J . Re-emergence of heart failure with a normal ejection fraction?. Eur Heart J. 2021; 43(5):427-429. DOI: 10.1093/eurheartj/ehab828. View

3.
Borlaug B, Redfield M . Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation. 2011; 123(18):2006-13. PMC: 3420141. DOI: 10.1161/CIRCULATIONAHA.110.954388. View

4.
Vaduganathan M, Claggett B, Greene S, Aggarwal R, Bhatt A, McMurray J . Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US. JAMA Cardiol. 2021; 6(12):1415-1423. PMC: 8444065. DOI: 10.1001/jamacardio.2021.3651. View

5.
Butler J, Packer M, Filippatos G, Ferreira J, Zeller C, Schnee J . Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction. Eur Heart J. 2021; 43(5):416-426. PMC: 8825259. DOI: 10.1093/eurheartj/ehab798. View